The effects of TGF-alpha, IL-1beta and PDGF on fibroblast adhesion to ECM-derived matrix and KGF gene expression.
The goal of this study was to elucidate the control mechanisms by which exogenous proteins regulate keratinocyte growth factor (KGF) expression in fibroblasts adhered to differing substrates and thereby provide insights into both fundamental in vitro cell signaling and cell-biomaterial interaction research. A serum-free culture system in which cells maintained their proliferative capacity was established and employed. The addition of transforming growth factor- alpha (TGF-alpha), interleukin-1beta (IL-1beta) and platelet-derived growth factor-BB (PDGF-BB) individually showed no effect on KGF protein release, however, IL-1beta addition led to increased KGF mRNA transcription, intracellular KGF protein synthesis, and granulocyte-macrophage colony-stimulating factor (GM-CSF) release. Intracellular KGF protein synthesis and extracellular release were enhanced when fibroblasts were treated with a combination of IL-1beta and PDGF-BB which suggests KGF synthesis and release are largely regulated by synergistic mechanisms. Surface-bound fibronectin-derived ligands and individual exogenous proteins promoted fibroblast adhesion to semi-interpenetrating polymer networks (sIPNs) but did not stimulate KGF release despite enhancement of KGF mRNA transcription. Additionally, serum conditioning was found to have a significant impact on KGF synthesis and the subsequent mechanisms controlling KGF release. This study demonstrates that KGF release from fibroblasts is likely regulated by multiple mechanisms involving post-transcriptional and exocytic controls which may be impacted by the presence of serum and how serum is removed from the in vitro cell environment.
Wang
Xintong
X
School of Pharmacy, University of Wisconsin-Madison, Madison, WI 53705, USA. xwang47@wisc.edu
Waldeck
Heather
H
Kao
Weiyuan J
WJ
D000077214:Becaplermin; D002448:Cell Adhesion / Q000187:drug effects / Q000235:genetics; D002452:Cell Count; D016895:Culture Media, Serum-Free; D020405:Dermis / Q000166:cytology; D005109:Extracellular Matrix / Q000187:drug effects / Q000235:genetics*; D051523:Fibroblast Growth Factor 7 / Q000235:genetics* / Q000378:metabolism; D005347:Fibroblasts / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D005353:Fibronectins / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000235:genetics / Q000378:metabolism; D006801:Humans; D053583:Interleukin-1beta / Q000494:pharmacology*; D010455:Peptides / Q000494:pharmacology; D010982:Platelet-Derived Growth Factor / Q000494:pharmacology*; D011137:Polystyrenes / Q000494:pharmacology; D020574:Proto-Oncogene Proteins c-sis; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D044967:Serum; D016211:Transforming Growth Factor alpha / Q000494:pharmacology*
D016895:Culture Media, Serum-Free; D005353:Fibronectins; D053583:Interleukin-1beta; D010455:Peptides; D010982:Platelet-Derived Growth Factor; D011137:Polystyrenes; D020574:Proto-Oncogene Proteins c-sis; D012333:RNA, Messenger; D016211:Transforming Growth Factor alpha; D051523:Fibroblast Growth Factor 7; D000077214:Becaplermin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor